Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease.
Merims
D
D
Ziv
I
I
Djaldetti
R
R
Melamed
E
E
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D019782:Riluzole / Q000627:therapeutic use*; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D018696:Neuroprotective Agents; D007980:Levodopa; D019782:Riluzole